If you live north of Atlanta and you haven't been supplementing, your vitamin D is almost certainly at its annual low right now. The UV-B rays responsible for skin synthesis can't reach the earth's surface at meaningful intensity above roughly 37° north latitude between November and March. That covers most of the continental US - and most of the year.
This isn't a fringe finding. The third National Health and Nutrition Examination Survey (NHANES III) found that approximately 35% of US adults have 25-hydroxyvitamin D below 20 ng/mL - the threshold most guidelines define as deficient. In late winter, that proportion climbs higher. Among women with darker skin pigmentation (which requires longer UV exposure for equivalent synthesis), rates of deficiency are substantially higher year-round.
What vitamin D actually does
Vitamin D is technically a hormone precursor, not a vitamin. Its active form - 1,25-dihydroxyvitamin D - binds to receptors in virtually every tissue in the body. The functions most people know about are skeletal: calcium absorption, bone mineralisation, fracture risk reduction. But the receptor distribution tells a wider story.
- Bone density - the most established function; deficiency accelerates perimenopausal bone loss.
- Immune regulation - vitamin D modulates both innate and adaptive immunity; deficiency associated with higher autoimmune disease incidence.
- Insulin sensitivity - receptor expression in pancreatic beta cells; low D associated with higher type 2 diabetes risk.
- Mood - seasonal affective disorder strongly correlates with latitude and winter vitamin D nadir.
- Muscle function - fast-twitch fibre recruitment requires adequate D; low levels increase fall risk independently of bone density.
The sufficiency debate
The IOM (Institute of Medicine) set its sufficiency threshold at 20 ng/mL based primarily on bone health endpoints. The Endocrine Society's 2011 Clinical Practice Guideline recommends 30 ng/mL as the minimum for overall health - and notes that optimal for bone and muscle function may require 40–60 ng/mL, particularly in perimenopausal and postmenopausal women.
Women-specific considerations
Perimenopause and bone loss
Bone density loss accelerates sharply in the two to three years around the final menstrual period - some women lose 2–3% of bone mass per year during this window. Adequate vitamin D (alongside calcium and resistance training) is the foundation of skeletal protection. Without it, estrogen-related bone loss compounds a nutrient deficit.
Vitamin K2 - the overlooked co-factor
Vitamin D drives calcium absorption. Vitamin K2 (specifically MK-7) directs that calcium into bone rather than arterial walls. Supplementing D without adequate K2 may increase soft-tissue calcification risk. The combination is well-studied and widely used in European bone health protocols; in the US it remains under-prescribed.
How much to take - and how to test
Most adults require 2,000–4,000 IU daily to maintain 25(OH)D above 40 ng/mL, depending on baseline, body weight (higher adiposity means greater volumetric dilution), and sun exposure habits. Individuals with obesity or malabsorption conditions may need 6,000–10,000 IU under clinical supervision.
Take vitamin D3 (cholecalciferol, not D2) with a fat-containing meal - it is fat-soluble and absorption drops significantly without dietary fat. Retest 25(OH)D after 90 days of consistent supplementation to confirm you've reached your target range.